<DOC>
	<DOCNO>NCT00105469</DOCNO>
	<brief_summary>The purpose study evaluate clinical microbial efficacy safety AzaSite compare tobramycin bacterial conjunctivitis . Adults child one year age old bacterial conjunctivitis least one eye eligible . Subjects randomly assign AzaSite group Tobramycin group . Three visit require study .</brief_summary>
	<brief_title>Evaluation Clinical Microbial Efficacy Safety AzaSite Compared Tobramycin Bacterial Conjunctivitis ( C-01-401-004 )</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male female subject , race , least 1 year age . Subjects must clinical diagnosis acute bacterial conjunctivitis exhibit mucopurulent purulent conjunctival discharge ( crusty sticky eyelid , globular yellow discharge ) redness least one eye . The symptoms bacterial conjunctivitis must present 3 day ( approximately 72 hour ) less . Must willing discontinue contact lens wear duration study . Any uncontrolled systemic disease debilitate disease . Use topical ophthalmic solution include tear substitute within 2 hour study . Use topical ophthalmic antiinflammatory agent within 48 hour study . Any active upper respiratory tract infection . Pregnant nursing female . Use antibiotic ( topical systemic ) within 72 hour enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Bacterial Conjunctivitis</keyword>
	<keyword>Pink Eye</keyword>
	<keyword>Conjunctivitis</keyword>
	<keyword>Eye Infection</keyword>
</DOC>